Mr. Lefton assists the Frazier Growth Buyout team in identifying, evaluating, acquiring, and advising healthcare services companies.
Mr. Lefton was Co-founder, Executive Chairman, and a Director of DSI Renal, a Frazier portfolio company which merged with U.S. Renal Care. He also serves as Executive Chairman for United Derm Partners, a Frazier portfolio company.
Prior to DSI, Mr. Lefton served as President, CEO, and Director of Odyssey Healthcare, then the largest publicly-traded hospice service provider. Prior to Odyssey, he co-founded SemperCare, an operator of long-term acute care hospitals, and served as President and CEO until the sale of the company to Select Medical. Earlier, he served in various capacities at Horizon Health Corporation, a provider of behavioral health services, including as President and Chief Operating Officer.
Mr. Lefton is currently a director of U.S. Renal Care. He previously served as a director of MedMark Services, Medical Staffing Networks (MSN), Sheridan Healthcare, Accuro Healthcare Solutions, Horizon Health Corporation, Signature Hospital Corporation, Pathology Partners, and Solis Women's Health.
Tulane University (B.A., M.B.A., M.P.H.)